NERV - Minerva Neurosciences, Inc.
7.3
-0.640 -8.767%
Share volume: 213,046
Last Updated: 03-11-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.16%
PREVIOUS CLOSE
CHG
CHG%
$7.94
-0.64
-0.08%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-01-2024 | 08-06-2024 | 11-05-2024 | 02-25-2025 | 05-13-2025 | 08-14-2025 | 11-05-2025 | |
| Cash flow financing | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | -45.166 K | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash flow | -6.094 M | 0.000 | 0.000 | 0.000 | -4.072 M | 0.000 | 0.000 | |
| Net income | -8.569 M | -8.233 M | 22.513 M | -4.272 M | -3.753 M | -3.259 M | -2.744 M | |
| Depreciation | 1.360 K | 1.361 K | 1.361 K | 1.360 K | 1.361 K | 1.360 K | 1.361 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash Change | -6.094 M | -3.937 M | -4.352 M | -5.167 M | -4.072 M | -2.042 M | -2.961 M |